Careplus Group Berhad Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wir verfügen derzeit nicht über ausreichende Analystenabdeckung, um Wachstum und Umsatz für Careplus Group Berhad zu prognostizieren.

Wichtige Informationen

n/a

Wachstumsrate der Gewinne

n/a

EPS-Wachstumsrate

Medical Equipment Gewinnwachstum	22.5%
Wachstumsrate der Einnahmen	n/a
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	None
Zuletzt aktualisiert	n/a

Jüngste Aktualisierungen zum künftigen Wachstum

Keine Aktualisierungen

Recent updates

Careplus Group Berhad (KLSE:CAREPLS) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Feb 07

Careplus Group Berhad (KLSE:CAREPLS) Shares Fly 63% But Investors Aren't Buying For Growth

Dec 18

Is Careplus Group Berhad (KLSE:CAREPLS) Using Debt Sensibly?

Nov 23

Little Excitement Around Careplus Group Berhad's (KLSE:CAREPLS) Revenues

Sep 07

Should You Be Adding Careplus Group Berhad (KLSE:CAREPLS) To Your Watchlist Today?

Apr 01

Investors Shouldn't Be Too Comfortable With Careplus Group Berhad's (KLSE:CAREPLS) Robust Earnings

Feb 26

Could The Careplus Group Berhad (KLSE:CAREPLS) Ownership Structure Tell Us Something Useful?

Feb 13

Careplus Group Berhad (KLSE:CAREPLS) Could Easily Take On More Debt

Jan 17

Our View On Careplus Group Berhad's (KLSE:CAREPLS) CEO Pay

Dec 13

In diesem Abschnitt stellen wir normalerweise Umsatz- und Gewinnwachstumsprognosen vor, die auf den Konsensschätzungen professioneller Analysten basieren, um den Anlegern zu helfen, die Fähigkeit des Unternehmens zur Gewinnerzielung zu verstehen. Da Careplus Group Berhad jedoch nicht genügend Daten aus der Vergangenheit zur Verfügung gestellt hat und keine Analystenprognose vorliegt, können die zukünftigen Erträge nicht zuverlässig durch Extrapolation von Vergangenheitsdaten oder anhand von Analystenprognosen berechnet werden.

Dies ist eine recht seltene Situation, da 97 % der von SimplyWall St erfassten Unternehmen über Finanzdaten aus der Vergangenheit verfügen.

Gewinn- und Umsatzwachstumsprognosen

KLSE:CAREPLS - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (MYR Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
9/30/2024	98	-24	-68	-68	N/A
6/30/2024	85	-26	-76	-72	N/A
6/30/2023	205	-147	-33	-23	N/A
12/31/2022	262	-122	-103	-58	N/A
9/30/2022	325	-119	-180	-94	N/A
6/30/2022	378	-81	-161	-68	N/A
3/31/2022	541	60	-53	60	N/A
12/31/2021	700	221	58	181	N/A
9/30/2021	721	279	164	292	N/A
6/30/2021	742	314	193	331	N/A
3/31/2021	612	245	133	253	N/A
12/31/2020	476	122	50	149	N/A
9/30/2020	455	81	64	118	N/A
6/30/2020	417	33	31	63	N/A
3/31/2020	385	-5	17	39	N/A
12/31/2019	365	-6	33	48	N/A
9/30/2019	346	-8	16	26	N/A
6/30/2019	351	-2	11	21	N/A
3/31/2019	345	-1	6	18	N/A
12/31/2018	339	-1	-1	14	N/A
9/30/2018	325	-1	-4	18	N/A
6/30/2018	314	-3	N/A	23	N/A
3/31/2018	314	-6	N/A	19	N/A
12/31/2017	323	-2	N/A	13	N/A
9/30/2017	316	1	N/A	3	N/A
6/30/2017	295	0	N/A	-7	N/A
3/31/2017	267	3	N/A	-6	N/A
12/31/2016	229	0	N/A	4	N/A
9/30/2016	210	0	N/A	9	N/A
6/30/2016	203	3	N/A	18	N/A
3/31/2016	195	4	N/A	16	N/A
12/31/2015	190	6	N/A	18	N/A
9/30/2015	182	5	N/A	20	N/A
6/30/2015	169	5	N/A	16	N/A
3/31/2015	159	4	N/A	24	N/A
12/31/2014	152	3	N/A	20	N/A
12/31/2013	141	1	N/A	0	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von CAREPLS über der Sparquote liegt (3.6%).

Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von CAREPLS schneller wachsen werden als der Markt MY

Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von CAREPLS in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von CAREPLS schneller wachsen werden als der Markt von MY.

Hohe Wachstumseinnahmen: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Einnahmen von CAREPLS schneller wachsen werden als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von CAREPLS in 3 Jahren voraussichtlich hoch sein wird

Careplus Group Berhad Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

First quarter 2025 earnings released: RM0.01 loss per share (vs RM0.14 loss in 1Q 2024)

New minor risk - Share price stability

Careplus Group Berhad, Annual General Meeting, Dec 04, 2024

Insufficient new directors

Careplus Group Berhad has filed a Follow-on Equity Offering.

Full year 2024 earnings released: RM0.042 loss per share (vs RM0.26 loss in FY 2023)

Careplus Group Berhad Announces Appointment of A Ley Lim as Joint Secretary

Careplus Group Berhad announced that it expects to receive MYR 17.47356 million in funding

New minor risk - Financial data availability

Careplus Group Berhad (KLSE:CAREPLS) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Careplus Group Berhad (KLSE:CAREPLS) Shares Fly 63% But Investors Aren't Buying For Growth

Is Careplus Group Berhad (KLSE:CAREPLS) Using Debt Sensibly?

Careplus Group Berhad, Annual General Meeting, Oct 25, 2023

Full year 2023 earnings released: RM0.26 loss per share (vs RM0.14 loss in FY 2022)

New minor risk - Shareholder dilution

Little Excitement Around Careplus Group Berhad's (KLSE:CAREPLS) Revenues

Full year 2023 earnings released: RM0.26 loss per share (vs RM0.14 loss in FY 2022)

New major risk - Revenue and earnings growth

Careplus Group Berhad Announces the Re-Designation of Puan Hazrena Binti Yahaya as Non-Independent Director from Independent Director

Careplus Group Berhad Announces Resignation of Madam Yew Yee Peng as Executive Director

Careplus Group Berhad Appoints Loo Hui Yan as Joint Secretary

Full year 2022 earnings released

Ansell Services (Asia) Sdn. Bhd. agreed to acquire 50% stake in CAREPLUS (M) SDN. BHD from Careplus Group Berhad (KLSE:CAREPLS) for MYR 37.5 million.

Careplus Group Berhad announced that it expects to receive MYR 49.8 million in funding

Careplus Group Berhad Announces Redesignation of Yee Chow Boi from Member of Remuneration Committee to Independent and Non Executive Chairman of Remuneration Committee

Now 21% undervalued

Third quarter 2022 earnings released: RM0.053 loss per share (vs RM0.015 profit in 3Q 2021)

Insufficient new directors

Careplus Group Berhad Announces Material Litigation Update

Second quarter 2022 earnings released: RM0.062 loss per share (vs RM0.20 profit in 2Q 2021)

First quarter 2022 earnings released: RM0.066 loss per share (vs RM0.23 profit in 1Q 2021)

Careplus Group Berhad, Annual General Meeting, Jun 08, 2022

Insufficient new directors

Should You Be Adding Careplus Group Berhad (KLSE:CAREPLS) To Your Watchlist Today?

Careplus Group Berhad (KLSE:CAREPLS) Seems To Use Debt Rather Sparingly

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Insufficient new directors

Is Careplus Group Berhad (KLSE:CAREPLS) A Risky Investment?

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Is Now The Time To Put Careplus Group Berhad (KLSE:CAREPLS) On Your Watchlist?

Insufficient new directors

Investor sentiment deteriorated over the past week

Upcoming dividend of RM0.02 per share

Second quarter 2021 earnings released: EPS RM0.20 (vs RM0.067 in 2Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of RM0.02 per share

Does Careplus Group Berhad (KLSE:CAREPLS) Have A Healthy Balance Sheet?

Investor sentiment deteriorated over the past week

Careplus Group Berhad Declares Interim Dividend for the Financial Year Ending 31 December 2021, Payable on 16 June 2021

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS RM0.23 (vs RM0.011 loss in FY 2019)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investors Shouldn't Be Too Comfortable With Careplus Group Berhad's (KLSE:CAREPLS) Robust Earnings

Full year 2020 earnings released

New 90-day low: RM1.94

Could The Careplus Group Berhad (KLSE:CAREPLS) Ownership Structure Tell Us Something Useful?

Investor sentiment deteriorated over the past week

Careplus Group Berhad (KLSE:CAREPLS) Could Easily Take On More Debt

Investor sentiment improved over the past week

New 90-day low: RM2.07

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

New 90-day low: RM2.34

Our View On Careplus Group Berhad's (KLSE:CAREPLS) CEO Pay

Careplus Group Berhad (KLSE:CAREPLS) and Tang Kin San completed the acquisition of Centro Heights Sdn. Bhd. from Chang Keng Chiang, Chang Sze Wei and Chang Kai Ping.

Market pulls back on stock over the past week

Market pulls back on stock over the past week

Market bids up stock over the past week

Market bids up stock over the past week

Ansell Limited (ASX:ANN) completed the acquisition 50% stake in CAREPLUS (M) SDN. BHD from Careplus Group Berhad (KLSE:CAREPLS).